A retrospective cohort study based on multi-center and propensity score matching was used to evaluate the effect of Tanreqing Injection on Influence of survival prognosis in patients with severe COVID-19 infectio
Phase 2
- Conditions
- severe COVID-19 infection
- Registration Number
- ITMCTR2024000103
- Lead Sponsor
- The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Conform to the criteria for moderate and severe diagnosis of the novel coronavirus infection Diagnosis and Treatment Protocol (Trial Version 9 and 10); Diagnostic criteria for patients with viral pneumonia in (Trial Version 9 and 10);
(2)Age range from 18 to 75 years old (including 18 and 75 years old), gender is not limited.
Exclusion Criteria
Exclude patients who experience the endpoint death event within 48 hours of hospital admission.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method